89例术后高度恶性脑胶质瘤预后影响因素分析

彭世义 邬蒙

彭世义, 邬蒙. 89例术后高度恶性脑胶质瘤预后影响因素分析[J]. 中国肿瘤临床, 2013, 40(1): 50-54. doi: 10.3969/j.issn.1000-8179.2013.01.013
引用本文: 彭世义, 邬蒙. 89例术后高度恶性脑胶质瘤预后影响因素分析[J]. 中国肿瘤临床, 2013, 40(1): 50-54. doi: 10.3969/j.issn.1000-8179.2013.01.013
Shiyi PENG, Meng WU. Analysis of prognosis of 89 patients with postoperative high-grade glioma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(1): 50-54. doi: 10.3969/j.issn.1000-8179.2013.01.013
Citation: Shiyi PENG, Meng WU. Analysis of prognosis of 89 patients with postoperative high-grade glioma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(1): 50-54. doi: 10.3969/j.issn.1000-8179.2013.01.013

89例术后高度恶性脑胶质瘤预后影响因素分析

doi: 10.3969/j.issn.1000-8179.2013.01.013
详细信息
    通讯作者:

    邬蒙  wumeng49@hotmail.com

Analysis of prognosis of 89 patients with postoperative high-grade glioma

More Information
  • 摘要:   目的  探讨高度恶性脑胶质瘤的预后以及预后影响因素。   方法  回顾分析江西省肿瘤医院2005年4月至2011年2月收治的89例高度恶性脑胶质瘤的临床资料, 其中手术全切43例, 部分切除46例; WHO3级45例, 4级44例。   结果  全组中位生存期13个月, 2年总生存率(OS)及无进展生存率(PFS)分别为43.2%和36.9%;单因素分析显示切除程度、病理分级、年龄是OS的影响因素(P < 0.05), 切除程度、脑室系统受侵、术后放疗是PFS的影响因素(P < 0.05), 多因素分析结果显示切除程度、年龄是OS的独立影响因素(P < 0.05);切除程度、术后放疗是PFS的独立影响因素(P < 0.05);全组共41例复发, 其中原位复发65.9%, 远隔部位复发34.1%;46例脑室系统受侵者, 11例出现远隔部位复发; 其余43例, 仅3例出现远隔部位复发。   结论  手术切除程度、年龄是影响OS的独立预后因素, 术后放疗能改善PFS; 原位复发是主要复发模式, 脑室受侵增加了远处播散概率。

     

  • 图  1  不同年龄组的总生存曲线比较

    Figure  1.  Overall survival curves in patients of different age groups

    图  2  不同病理分级的总生存曲线比较

    Figure  2.  Overall survival curves in patients with various pathological grades

    图  3  不同手术切除程度的总生存曲线比较

    Figure  3.  Overall survival curves in patients with resection of different extent

    图  4  术后是否放疗的无进展生存曲线比较

    Figure  4.  Progression-free survival curves in patients with or without radiotherapy after surgery

    图  5  不同手术切除程度的无进展生存曲线比较

    Figure  5.  Progression-free survival curves in patients with resection of different extent

    图  6  脑室系统是否受侵的无进展生存曲线比较

    Figure  6.  Progression-free survival curves in patients with or without ventriclular violation

    表  1  影响OS的多因素分析

    Table  1.   Multivariate analysis of prognostic factors for OS rates in 89 high grade glioma patients

    表  2  影响PFS的多因素分析

    Table  2.   Multivariate analysis of prognostic factors for PFS rates in 89 high grade glioma patients

    表  3  影响OS及PFS的单因素分析

    Table  3.   Univariate analysis of prognostic factors affecting OS and PFS rates in 89 high grade glioma patients

    表  4  脑室系统是否受侵与复发部位关系  例

    Table  4.   Relationship between the location of tumor recurrence and damaged ventricle(n)

  • [1] 汪洋, 盛晓芳, 高晶, 等. 高分级神经胶质瘤112例术后放、化疗疗效及其预后分析[J]. 肿瘤, 2009, 29(7): 688-672. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLL200907020.htm
    [2] Duncan GG, Goodman GB, Ludgate CM, et al. The treatment ofadult supratentorial high grade astrocytomas[J]. J Neuro Oncol, 1992, 13(1): 63-72.
    [3] atalán-Uribarrena G, Bilbao-Barandica G, Pomposo-Gaztelu I, etal. Prognostic factors and survival in a prospective cohort of pa tients with high-grade glioma treated with carmustine wafers or te mozolomide on an intention-to-treat basis[J]. Acta Neurochir, 2012, 154(2): 211-222. doi: 10.1007/s00701-011-1199-7
    [4] Irwin C, Hunn M, Purdie G, et al. Delay in radiotherapy shortenssurvival in patients with high grade glioma[J]. J Neuro Oncol, 2007, 85(3): 339-343. doi: 10.1007/s11060-007-9426-z
    [5] Mohamed A, Ahmed E. Hypofractionated conformal irradiation ofpatients with malignant glioma[J]. J Egypt Natl Cancer Insti, 2012, 24: 139-143. doi: 10.1016/j.jnci.2012.07.001
    [6] Dea N, Fournier-Gosselin MP, Mathieu D, et al. Does extent of re section impact survival in patients bearing glioblastoma[J]. Can JNeurol Sci, 2012, 39(5): 632-637. doi: 10.1017/S0317167100015377
    [7] Uehara K, Sasayama T, Miyawaki D, et al. Patterns of failure aftermultimodal treatments for high-grade glioma: effectiveness ofMIB-1 labeling index[J]. Radiat Oncol, 2012, 26(7): 104-115.
    [8] Yamaguchi S, Kobayashi H, Terasaka S, et al. The impact of extentof resection and histological subtype on the outcome of adult pa tients with high-grade gliomas[J]. Jpn J Clin Oncol, 2012, 42(4): 270-277. doi: 10.1093/jjco/hys016
    [9] 邹燕梅, 熊华, 于世英. 恶性胶质瘤术后治疗疗效及预后因素分析[J]. 实用癌症杂志, 2009, 24(2): 184-187. doi: 10.3969/j.issn.1001-5930.2009.02.023
    [10] Izmalov TR, Pan'shin GA, Datsenko PV. The role of age and tu mor grade in the choice of fractionation regimen in patients with high-grade gliomas[J]. Vopr Onkol, 2012, 58(3): 374-379.
    [11] Lee SW, Fraass BA, Marsh LH, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocyto mas: a quantitative dosimetric study[J]. Int J Radiat Oncol BiolPhys, 1999, 43(1): 79-88. doi: 10.1016/S0360-3016(98)00266-1
    [12] Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiothera py[J]. J Clin Oncol, 2002, 20(6): 1635-1642. doi: 10.1200/JCO.2002.20.6.1635
    [13] Wei T, Denice D, Jia H, et al. Conditional survival of high-gradeglioma in Los Angeles County during the year 1990-2000[J]. J Neu ro Oncol, 2012, 110(1): 145-152. doi: 10.1007/s11060-012-0949-6
    [14] 顾文栋, 裴红蕾. 69例脑胶质瘤术后三维适形放射治疗临床分析[J]. 中国神经肿瘤杂志, 2011, 9(2): 124-127.
    [15] Hess CF, Schaaf JC, Kortmann RD, et al. Malignant glioma: pat terns of failure following individually tailored limited volume irradi ation[J]. Radiother Oncol, 1994, 30(2): 146-149. doi: 10.1016/0167-8140(94)90044-2
  • 加载中
图(6) / 表(4)
计量
  • 文章访问数:  8
  • HTML全文浏览量:  0
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-09-06
  • 修回日期:  2012-11-01

目录

    /

    返回文章
    返回